Psychedelics as Novel Therapeutics for Chronic Pain in Veterinary Medicine: A Hypothesis-Driven Protocol Using Low-Dose 1-Cyclopropionyl-D-lysergic Acid Diethylamide (1cp-LSD) in Canine Osteoarthritis.
Animals : an open access journal from MDPI December 19, 2025 Elisa Hernández-Álvarez, Andrea Acosta-Dacal, Octavio P Luzardo et al. 1 citation
Low-dose psychedelics have shown potential in modulating chronic pain in humans, yet their application in veterinary medicine remains unexplored. This study protocol proposes to investigate the therapeutic potential of low-dose oral administration of 1-cyclopropionyl-D-lysergic acid diethylamide (1cp-LSD), a legal LSD analogue in certain countries, for the management of chronic pain in...
DOI: 10.3390/ani16010003 (opens in new tab)
Full text (opens in new tab)
1cp-LSD
Analgesic
Caregiver expectations
Chronic pain
+4